Heart Surgery Drug Pulled From Market
New York Times article about Bayer AG's decision to stop selling aprotinin (Trasylol) after a study suggested that it increases death rates. (November 06, 2007)
[Mozilla Genie]
Last update:
March 11, 2015 at 13:54:12 UTC
Health
Home
News
Recreation
Reference
Regional
Science
Shopping
Society
Sports
All Languages
Arts
Business
Computers
Games